Halozyme Therapeutics shares owned by Snyder Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Snyder Capital Management
from 13F filings
Historical chart of Snyder Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Snyder Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Snyder Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $168M | 4.1M | 40.68 |
2023-09-30 | $165M | 4.3M | 38.20 |
2023-06-30 | $156M | 4.3M | 36.07 |
2023-03-31 | $164M | 4.3M | 38.19 |
2022-12-31 | $227M | 4.0M | 56.90 |
2022-09-30 | $175M | 4.4M | 39.54 |
2022-06-30 | $181M | 4.1M | 44.00 |
2022-03-31 | $161M | 4.0M | 39.88 |
2021-12-31 | $163M | 4.1M | 40.21 |
2021-09-30 | $139M | 3.4M | 40.68 |
2021-06-30 | $144M | 3.2M | 45.41 |
2021-03-31 | $122M | 2.9M | 41.69 |
2020-12-31 | $141M | 3.3M | 42.71 |
2020-09-30 | $89M | 3.4M | 26.28 |
2020-06-30 | $91M | 3.4M | 26.81 |
2020-03-31 | $61M | 3.4M | 17.99 |
2019-12-31 | $62M | 3.5M | 17.73 |
2019-09-30 | $42M | 2.7M | 15.51 |
2019-06-30 | $47M | 2.7M | 17.18 |
2019-03-31 | $46M | 2.8M | 16.10 |
2018-12-31 | $42M | 2.8M | 14.63 |
2018-09-30 | $43M | 2.4M | 18.17 |
2018-06-30 | $40M | 2.4M | 16.87 |
2018-03-31 | $46M | 2.4M | 19.59 |
2017-12-31 | $48M | 2.4M | 20.26 |
2017-09-30 | $43M | 2.5M | 17.37 |
2017-06-30 | $32M | 2.5M | 12.82 |
2017-03-31 | $30M | 2.3M | 12.96 |
2016-12-31 | $21M | 2.1M | 9.88 |
2016-09-30 | $27M | 2.2M | 12.08 |
2016-06-30 | $20M | 2.3M | 8.63 |
2016-03-31 | $16M | 1.7M | 9.47 |